MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ESLA — Estrella Immunopharma, Inc. Common Stock
NasdaqEstrella Immunopharma, Inc. Common Stock
$0.47
-0.01(-1.47%)
- O
- 0.46
- H
- 0.51
- L
- 0.46
- V
- 14.49K
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About ESLA
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
SectorNot available
IPO DateOct 2, 2023
EmployeesNot available
Stock ExchangeNasdaq
Ticker SymbolESLA
Websitehttps://www.estrellabio.com
Key Financial Statistics
| Market Cap | $20.36M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $0.43 - $3.15 |
| 52-Week Avg Volume | 142.8K |
| VWAP | $0.48 |
| Transactions | 951 |
| Total Recorded Bars | 1,269 days |